Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2017. Start Trial.
Date Value
October 08, 2026 2.985
October 07, 2026 3.105
October 06, 2026 3.19
October 05, 2026 3.085
October 02, 2026 3.055
October 01, 2026 3.105
September 30, 2026 3.240
September 29, 2026 3.443
September 28, 2026 3.405
September 25, 2026 3.450
September 24, 2026 3.420
September 23, 2026 3.556
September 22, 2026 3.596
September 21, 2026 3.596
September 18, 2026 3.586
September 17, 2026 3.751
September 16, 2026 3.911
September 15, 2026 4.507
September 14, 2026 5.824
September 11, 2026 4.312
September 10, 2026 3.095
September 09, 2026 2.995
September 08, 2026 2.624
September 04, 2026 3.017
September 03, 2026 3.16
Date Value
September 02, 2026 3.543
September 01, 2026 3.617
August 31, 2026 3.581
August 28, 2026 3.756
August 27, 2026 3.778
August 26, 2026 3.632
August 25, 2026 3.752
August 24, 2026 3.828
August 21, 2026 3.613
August 20, 2026 3.530
August 19, 2026 3.592
August 18, 2026 3.448
August 17, 2026 3.568
August 14, 2026 3.706
August 13, 2026 3.723
August 12, 2026 3.782
August 11, 2026 3.916
August 10, 2026 4.014
August 07, 2026 4.008
August 06, 2026 3.768
August 05, 2026 3.975
August 04, 2026 4.083
August 03, 2026 3.864
July 31, 2026 3.674
July 30, 2026 3.854

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 2.606
Alnylam Pharmaceuticals, Inc. 22.96
Savara, Inc. 7.042
Vericel Corp. 5.544
Biogen, Inc. 1.770

Price to Book Value Related Metrics

Price 6.27
Earnings Yield -1.44K%
Market Cap 11.20M